Literature DB >> 26772949

Complications Related to the Treatment of Slipped Capital Femoral Epiphysis.

John Roaten1, David D Spence2.   

Abstract

Slipped capital femoral epiphysis (SCFE) is a condition of the immature hip in which mechanical overload of the proximal femoral physis results in anterior and superior displacement of the femoral metaphysis relative to the epiphysis. The treatment of SCFE is surgical, as the natural history of nonsurgical treatment is slip progression and early arthritis. Despite advances in treatment, much controversy exists regarding the best treatment, and complication rates remain high. Complications include osteonecrosis, chondrolysis, SCFE-induced impingement, and related articular degeneration, fixation failure and deformity progression, growth disturbance of the proximal femur, and development of bilateral disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chondrolysis; Complications; Impingement; Osteoarthritis; Osteonecrosis; Slipped capital femoral epiphysis

Mesh:

Year:  2016        PMID: 26772949     DOI: 10.1016/j.ocl.2015.09.013

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  10 in total

1.  A Retrospective Study of Risk Factors and Outcomes in the Surgical Management of Slipped Capital Femoral Epiphysis.

Authors:  Winston Jin; Sarah Farrell; Eva Habib; Ash Sandhu; Jeffrey N Bone; Emily Schaeffer; Kishore Mulpuri
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-07-06

2.  SUFE and the internet: are healthcare information websites accessible to parents?

Authors:  Andrea Mc Carthy; Colm Taylor
Journal:  BMJ Paediatr Open       Date:  2020-10-20

3.  RADIOLOGICAL RESULTS OF SEVERE SCFE TREATMENT AT IOT-FMUSP FROM 2012 TO 2018.

Authors:  Edelvan Gabana; Bruno Sergio Ferreira Massa; Carlos Augusto Malheiros Luzo; Paulo Roberto Dos Reis; Jorge Dos Santos Silva; Kodi Edson Kojima
Journal:  Acta Ortop Bras       Date:  2022-04-15       Impact factor: 0.683

4.  Prophylactic fixation of the unaffected contralateral side in children with slipped capital femoral epiphysis seems favorable: A systematic review.

Authors:  Steven J C Vink; Renée A van Stralen; Sophie Moerman; Christiaan J A van Bergen
Journal:  World J Orthop       Date:  2022-05-18

Review 5.  ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.

Authors:  Janey S A Pratt; Allen Browne; Nancy T Browne; Matias Bruzoni; Megan Cohen; Ashish Desai; Thomas Inge; Bradley C Linden; Samer G Mattar; Marc Michalsky; David Podkameni; Kirk W Reichard; Fatima Cody Stanford; Meg H Zeller; Jeffrey Zitsman
Journal:  Surg Obes Relat Dis       Date:  2018-03-23       Impact factor: 4.734

Review 6.  Predicting subsequent contralateral slipped capital femoral epiphysis: an evidence-based approach.

Authors:  Ishaan Swarup; Ronit Shah; Shivani Gohel; Keith Baldwin; Wudbhav N Sankar
Journal:  J Child Orthop       Date:  2020-04-01       Impact factor: 1.548

7.  Hip arthroscopy following slipped capital femoral epiphysis fixation: chondral damage and labral tears findings.

Authors:  Javier Besomi; Valeria Escobar; Santiago Alvarez; Juanjose Valderrama; Jaime Lopez; Claudio Mella; Joaquin Lara; Claudio Meneses
Journal:  J Child Orthop       Date:  2021-02-01       Impact factor: 1.548

8.  Comparing complications of outpatient management of slipped capital femoral epiphysis and Blount's disease: A database study.

Authors:  Achraf Jardaly; Timothy W Torrez; Gerald McGwin; Shawn R Gilbert
Journal:  World J Orthop       Date:  2022-04-18

9.  The Effect of the Type of Screw Fixation Used in the Treatment of Slipped Capital Femoral Epiphysis.

Authors:  Tyler Rudolph; Katie Rooks; Haemish Crawford; Michael van der Merwe
Journal:  Adv Orthop       Date:  2022-09-20

Review 10.  Factors Affecting Outcomes of Slipped Capital Femoral Epiphysis.

Authors:  Panagiotis V Samelis; Eftychios Papagrigorakis; Apostolos-Lykourgos Konstantinou; Harris Lalos; Panagiotis Koulouvaris
Journal:  Cureus       Date:  2020-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.